Bioxytran, Inc.
BIXT
$0.04
$0.000.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.39M | 1.24M | 1.04M | 1.52M | 2.11M |
| Depreciation & Amortization | 11.50K | 11.50K | 8.80K | 7.80K | 7.90K |
| Other Operating Expenses | -3.00K | -3.00K | -3.00K | -- | -- |
| Total Operating Expenses | 1.85M | 1.74M | 1.58M | 1.97M | 2.23M |
| Operating Income | -1.85M | -1.74M | -1.58M | -1.97M | -2.23M |
| Income Before Tax | -2.12M | -2.35M | -2.46M | -3.16M | -2.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.12 | -2.35 | -2.46 | -3.16 | -2.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00 | 0.00 | 0.00 | 13.30K |
| Net Income | -2.12M | -2.35M | -2.46M | -3.16M | -2.37M |
| EBIT | -1.85M | -1.74M | -1.58M | -1.97M | -2.23M |
| EBITDA | -1.84M | -1.72M | -1.57M | -1.96M | -2.22M |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Diluted | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 367.22M | 359.60M | 397.00M | 484.77M | 559.38M |
| Average Diluted Shares Outstanding | 367.22M | 359.60M | 397.00M | 484.77M | 559.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |